New CAR-T Therapy achieves positive results in a high proportion of patients with a refractory type of lymphoma April 29, 2025 New CAR-T Therapy achieves positive results in a high proportion of patients with a refractory type of lymphoma
Complement and endothelium are key to understanding the development of thrombotic micronagiopathies June 05, 2020 Complement and endothelium are key to understanding the development of thrombotic micronagiopathies
Scientific publishing production between April and June June 03, 2020 Scientific publishing production between April and June
CAR-T cells against B-cell Acute Lymphoblastic Leukemia May 27, 2020 CAR-T cells against B-cell Acute Lymphoblastic Leukemia
Research with COVID19 and online scientific seminars set the starting point for de-escalation May 26, 2020 Research with COVID19 and online scientific seminars set the starting point for de-escalation
The Proteomics Unit joins the COVID-19 Mass Spectrometry Coalition May 18, 2020 The Proteomics Unit joins the COVID-19 Mass Spectrometry Coalition
First Epigenetic Study in 3D Human Cancer Cells May 13, 2020 First Epigenetic Study in 3D Human Cancer Cells
The Josep Carreras Leukaemia Research Institute participates in the MSCA RISE cONCReTE project May 11, 2020 The Josep Carreras Leukaemia Research Institute participates in the MSCA RISE cONCReTE project
Manel Esteller participates in the Exceptional Responders to Cancer Treatments Initiative May 06, 2020 Manel Esteller participates in the Exceptional Responders to Cancer Treatments Initiative
Discovered the physiopathological mechanisms underlying the most common pediatric Leukemia May 05, 2020 Discovered the physiopathological mechanisms underlying the most common pediatric Leukemia
